Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2023-05-16 00:00:00 ET · period of report 2023-05-15 · accession 0001055726-23-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-16 | 2023-05-16 | INO | BENITO SIMON X | Dir | M - OptEx | — | +19.0K | 94.3K | +25% | — |
| D | 2023-05-16 | 2023-05-16 | INO | BENITO SIMON X | Dir | M - OptEx | $0.00 | -19.0K | 0 | -100% | $0 |
| DM | 2023-05-16 | 2023-05-15 | INO | BENITO SIMON X | Dir | A - Grant | $0.00 | +61.0K | 35.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-16 | M | A | 19,000 | — | 94,305 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023. |
| 2 | Derivative | Restricted Stock Unit | 2023-05-16 | M | D | 19,000 | $0.00 | 0 | D | — · — to — | 19,000 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023. |
| 3 | Derivative | Restricted Stock Unit | 2023-05-15 | A | A | 26,000 | $0.00 | 26,000 | D | — · — to — | 26,000 Common Stock | (F2) This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. |
| 4 | Derivative | Common Stock Options | 2023-05-15 | A | A | 35,000 | $0.00 | 35,000 | D | $0.77 · — to 2033-05-15 | 35,000 Common Stock | (F2) This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. (F3) Options to vest 100% on May 15, 2024. |